Clinical trial
URIPRENE: Clinical Study to Evaluate the Safety and Device Performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
NCT04565795 is registered in ClinicalTrials.gov with Adva-Tec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- URIPRENE: Clinical Study to Evaluate the Safety and Device Performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- Lead sponsor
- Adva-Tec
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2022
- Completion date
- September 30, 2026
- Enrollment
- 87 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.